Residual Risk in ASCVD and CKD
Expert Discussions on Residual Systemic Inflammation in ASCVD and CKD

Released: August 27, 2024

Expiration: August 26, 2025

Erin Michos
Erin Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Mark J. Sarnak
Mark J. Sarnak, MD, MS

Activity

Progress
1
Course Completed

In this CCO Nephrology podcast episode, hear from cardiologist Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, and nephrologist Mark J. Sarnak, MD, MS, as they explore new and emerging strategies to target residual risk associated with systemic inflammation in patients with ASCVD and CKD.   

 Episode outline:   

  • The relationship among systemic inflammation, ASCVD, and CKD
  • The role of cardiologists and nephrologists in screening and mitigating systemic inflammation

To learn more about targeting residual risk associated with systemic inflammation, find more educational activities and resources with the links below: